Company Badge
USPTO Data Jan 1 1976 - Nov 10 2026
6 Patents
#1 in Baillargues
#2,493 in France
Medesis Pharma
Forward Citations = 3
13 inventors:
Medesis Pharma
Calculating rank
% Expired Patents = 16.7
EPO Patents = 4
Forward Citations = 3
Loading Chart...
Loading Chart...
13 inventors (with patents filed for the assignee):
Jean-Claude Maurel (6 out of 9 patents)
Elsa Compte (3 out of 3 patents)
Cyril Lavaud (2 out of 2 patents)
4. Yannick Guari (1 out of 3 patents)
5. Joulia Guari (1 out of 1 patent)
6. Jérôme Long (1 out of 1 patent)
7. Caroline Bauer (1 out of 1 patent)
8. Olivier Gremy (1 out of 1 patent)
9. Laurent Miccoli (1 out of 1 patent)
10. Jaime Francisco Angulo-Mora (1 out of 2 patents)
11. Lorraine Benigno-Anton (1 out of 1 patent)
12. Sophie Grives-Jerphagnon (1 out of 1 patent)
13. Patrick Maurel (1 out of 1 patent)
6 patents:
Company Overview
Medesis Pharma is a leading pharmaceutical company dedicated to improving healthcare outcomes. Our innovative approach to drug development focuses on creating safe and effective treatments for a variety of medical conditions. With a commitment to quality and patient care, we strive to make a positive impact on the global healthcare industry.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medesis Pharma. Retrieved from https://idiyas.com/company/medesis-pharma
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]